MD, PhD
Dr Xenofon Baraliakos is a Senior Consultant and scientific coordinator at the Rheumazentrum Ruhrgebiet Herne and Professor for Internal Medicine and Rheumatology at the Ruhr-University Bochum, Germany.
He studied Human Medicine at the universities of Magdeburg and Berlin, Germany and went on to receive a PhD degree in 2005 with a thesis entitled ‘MRI examinations of the spine in patients with ankylosing spondylitis before and after therapy with the monoclonal anti-TNF-α antibody infliximab’.
Dr. Baraliakos received his official Board Degrees in orthopaedic surgery in 2007 and in Internal Medicine and Rheumatology in 2014. His research interests include clinical and academic research in the field of spondyloarthritides, with special emphasis on imaging outcomes and treatment of the disease.
Among others, Dr Baraliakos won the EWRR Award, in 2005, the EULAR Young Investigator Award, in 2006 and 2008, the German patient’s AS Society Award in 2010 and the 2014 Award for Excellence in Clinical Research from the European Society for Clinical Investigations.
Dr Baraliakos is the current President of ASAS (Assessment of Spondyloarthritis International Society) and Past Chair of the EULAR standing committee for musculoskeletal imaging and member of the EULAR Executive Committee.
He holds membership of the American College of Rheumatology (ACR), the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) and the German Society of Rheumatology. He also acts as a reviewer and is an Associate Editor in a number of major rheumatological journals.